Cheng T, Zhang X-L, Hu J-J, Li B, Wang Q
Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China
Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Bone Joint Res. 2017 Sep;6(9):566-571. doi: 10.1302/2046-3758.69.BJR-2017-0066.R2.
Surgeons face a substantial risk of infection because of the occupational exposure to blood-borne pathogens (BBPs) from patients undergoing high-risk orthopaedic procedures. This study aimed to determine the seroprevalence of four BBPs among patients undergoing joint arthroplasty in Shanghai, China. In addition, we evaluated the significance of pre-operative screening by calculating a cost-to-benefit ratio.
A retrospective observational study of pre-operative screening for BBPs, including hepatitis B and C viruses (HBV and HCV), human immunodeficiency virus (HIV) and Treponema pallidum (TP), was conducted for sequential patients in the orthopaedic department of a large urban teaching hospital between 01 January 2009 and 30 May 2016. Medical records were analysed to verify the seroprevalence of these BBPs among the patients stratified by age, gender, local origin, type of surgery, history of previous transfusion and marital status.
Of the subjects who underwent arthroplasty surgery in our institution, pre-operative screening tests were available for 96.1% (11 609 patients). The seroprevalence of HBV, HCV, HIV and TP was 5.47%, 0.45%, 0.08% and 3.6%, respectively. A total of 761 seropositive cases (68.4%) were previously undiagnosed. Pre-operative screening for HIV resulted in a low cost to benefit ratio, followed by HCV and HBV.
Routine HCV and HIV screening prior to joint arthroplasty is not a cost-effective strategy. Considering the high rate of undiagnosed patients and the shortage of protective options, targeted pre-operative screening for HBV and syphilis should be considered for the protection of healthcare workers in China who have not been vaccinated.: 2017;6:566-571.
由于在进行高风险骨科手术时职业暴露于患者的血源性病原体(BBP),外科医生面临着较高的感染风险。本研究旨在确定中国上海接受关节置换术患者中四种血源性病原体的血清流行率。此外,我们通过计算成本效益比来评估术前筛查的意义。
对一家大型城市教学医院骨科2009年1月1日至2016年5月30日连续收治的患者进行血源性病原体术前筛查的回顾性观察研究,包括乙型和丙型肝炎病毒(HBV和HCV)、人类免疫缺陷病毒(HIV)和梅毒螺旋体(TP)。分析病历以核实这些血源性病原体在按年龄、性别、籍贯、手术类型、既往输血史和婚姻状况分层的患者中的血清流行率。
在我们机构接受关节置换手术的受试者中,96.1%(11609例患者)有术前筛查结果。HBV、HCV、HIV和TP的血清流行率分别为5.47%、0.45%、0.08%和3.6%。共有761例血清阳性病例(68.4%)此前未被诊断。HIV术前筛查的成本效益比很低,其次是HCV和HBV。
关节置换术前常规进行HCV和HIV筛查不是一种具有成本效益的策略。考虑到未确诊患者的比例较高以及防护措施的短缺,在中国应考虑对未接种疫苗的医护人员进行有针对性的HBV和梅毒术前筛查,以保护他们。:2017;6:566 - 571。